Area of research
Cardiology and Cardiovascular Medicine
Research interest
Research interests include Medicine, Ejection fraction, Heart failure, Hazard ratio, Internal medicine, and Digoxin.
TRAIL-receptor 2—a novel negative regulator of p53
Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation
Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial
Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction
Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate
Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction